entertainment -WSS

entertainment

author：Wikipedia 2025-09-03 09:35:45 - browse：94

Zepbound, a injectable drug on a gradient background of dark purple and green — biotech coverage from STAT — Illustration: STAT; Source: Eli Lilly/AP

Eli Lilly’s blockbuster diabetes and obesity drug improved living scarring in a mid-stage study of the liver disease MASH, adding to positive data announced earlier this year.

The study tested three doses of tirzepatide, sold commercially as Mounjaro or Zepbound. The percentage of patients who experienced a greater than one-stage improvement in scarring, or fibrosis, without worsening of their disease was 54.9%, 51.3%, and 51.0% from the lowest to highest doses.

When compared with the 29.7% of patients on placebo who achieved this outcome, the results were statistically significant, according to an abstract of data that will be presented at the annual meeting of the European Association for the Study of the Liver.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Why are elite athletes different? Take a look at their microbes

focus

WSS

Ransomware attacks on hospitals: Study outlines patient impact

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

The science behind Janet Jackson's pregnancy at 49

PBM reforms clear House panel

Readout LOUD podcast: A CRISPR milestone, biotech mixology

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

Wikipedia

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

knowledge

George Santos makes 1st court appearance after pleading not guilty to 13 counts

The battle over the Brookhaven Landfill on Long Island

BioMarin wins approval for gene therapy to treat hemophilia A

Ask STAT: What do you want to know about ChatGPT in medicine?

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Colonoscopy at 40? Study finds a possible benefit

Bright Health sells Medicare Advantage business to Molina

Astellas still sees hope in its gene therapy after four deaths

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

3 hurdles to bringing medical devices to the U.S. market

Wikipedia

Colonoscopy at 40? Study finds a possible benefit

PBM reforms clear House panel

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Morphosys mixed study results for blood cancer drug

Why are elite athletes different? Take a look at their microbes

Surge of respiratory disease in China has likely explanation

focus

Wikipedia

focus

Wikipedia